Delivery Order SPE2DB20D2104-SPE2DB25FMYAD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,775.57 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is a prescription antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,954.30 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a $27,345.32 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $6,795.56 to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV treatment and prevention. The contract was competitively awarded without set-aside provisions and is classified as firm fixed price, with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $5,795.72 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV treatment medication combining emtricitabine and tenofovir alafenamide,...
- The Defense Logistics Agency awarded a $33,272.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-unit packaging) with a completion date of July 22, 2025. This non-set-aside competitive award was issued on July 21, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's ongoing pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $8,697.19 under a firm fixed price arrangement. This non-set-aside delivery order, issued on August 12, 2025, with completion scheduled for August 13, 2025, will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency awarded a $24,347.36 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. DESCOVY is an antiretroviral medication...
- The Defense Logistics Agency awarded a delivery order valued at $14,991.82 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYADDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,771.46 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 tablets, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the pharmaceutical supply requirements within the federal medical procurement network. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle that extends through December 2026 and provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical contracts with the Defense Logistics Agency, supplying a wide range of medications and medical commodities to support the Defense Health Agency and related government healthcare systems. The company's demonstrated capability to fulfill federal procurement requirements through open competition positions it as a critical vendor within the military supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 8/15/25 |